Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.

In 11 patients with severe angina pectoris a new beta-blocking drug, atenolol (Tenormin; I.C.I.66082), was found in a double-blind randomized trial to reduce significantly the frequency of anginal attacks (P less than 0-001) and the amount of trinitrin consumed (P less than 0-03) in comparison with...

Full description

Saved in:
Bibliographic Details
Main Authors: Roy, P, Day, L, Sowton, E
Format: Artigo
Language:Inglês
Published: 1975
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1674130/
https://ncbi.nlm.nih.gov/pubmed/238716
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items